Lalau, Jean-Daniel

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,829

Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4

Lalau, J.-D., Kajbaf, F., Bennis, Y., Hurtel-Lemaire, A.-S., Belpaire, F., & De Broe, M. E. (2018) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 162

Compliance with a multidisciplinary team meeting’s decision prior to bariatric surgery protects against major postoperative complications

Rebibo, L., Maréchal, V., De Lameth, I., Dhahri, A., Escoffier, I., Lalau, J.-D., & Regimbeau, J.-M. (2017) · Surgery for Obesity and Related Diseases

Bariatric Surgery and OutcomesBody Contouring and Surgery

Cited by 35